Search - tctmd.com

Displaying 41 - 60 of 571

Sort: Relevancy | Date

Presentation TCT 2024

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Presentation TCT 2024

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Presenter: Kazuki Aihara

October 29, 2024

Presentation TCT 2024

TCT 1364: A Case of Very Late Stent Thrombosis 7 Years After Drug-Eluting Stent Implantation

Presenter: Masaya Kusuda

October 29, 2024

Presentation TCT 2024

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Presenter: Woo Jin Ahn

October 29, 2024

Presentation TCT 2024

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

Presenter: Nancy Virginia

October 29, 2024

Presentation TCT 2024

TCT 39: Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent

Presenter: Yuko Kiyohara

October 28, 2024

Presentation TCT 2024

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

Presenter: Armando Perez de Prado

October 28, 2024

Presentation TCT 2024

TCT 441: Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: A Systematic Review and Meta-Analysis

Presenter: Denise Pellegrini

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

Presenter: Han Su Park

October 28, 2024

Presentation TCT 2024

TCT 392: Impact of Drug-Eluting Stent Eccentricity on Clinical Outcomes After Rotational Atherectomy for Calcified Coronary Artery

Presenter: Hisanori Yui

October 28, 2024

Presentation TCT 2024

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Presenter: Juan F. Iglesias

October 28, 2024

Presentation TCT 2024

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

Presenter: Hesham Refaat

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Presenter: Jeremy Levett

October 28, 2024

Presentation TCT 2024

TCT 358: Case Series of Coronary Artery Pseudoaneurysm With Extra Luminal Migration of Drug Eluting Stent Following Percutaneous Coronary Intervention

Presenter: Arun Mohanty

October 27, 2024

Presentation TCT 2024

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Presenter: Emi Kearon

October 27, 2024

Advertisement

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

TCT 1364: A Case of Very Late Stent Thrombosis 7 Years After Drug-Eluting Stent Implantation

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

TCT 39: Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

TCT 441: Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: A Systematic Review and Meta-Analysis

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

TCT 392: Impact of Drug-Eluting Stent Eccentricity on Clinical Outcomes After Rotational Atherectomy for Calcified Coronary Artery

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

TCT 358: Case Series of Coronary Artery Pseudoaneurysm With Extra Luminal Migration of Drug Eluting Stent Following Percutaneous Coronary Intervention

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content